Newron Pharmaceuticals Statistics

Total Valuation

ETR:NP5 has a market cap or net worth of EUR 155.30 million. The enterprise value is 195.94 million.

Market Cap	155.30M
Enterprise Value	195.94M

Important Dates

The last earnings date was Tuesday, April 1, 2025.

Earnings Date	Apr 1, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+15.30%
Shares Change (QoQ)	+21.68%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	18.88M

Valuation Ratios

The trailing PE ratio is 9.80.

PE Ratio	9.80
Forward PE	n/a
PS Ratio	3.02
PB Ratio	106.51
P/TBV Ratio	106.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.43, with an EV/FCF ratio of -11.12.

EV / Earnings	12.37
EV / Sales	3.81
EV / EBITDA	7.43
EV / EBIT	7.49
EV / FCF	-11.12

Financial Position

The company has a current ratio of 2.60, with a Debt / Equity ratio of 34.62.

Current Ratio	2.60
Quick Ratio	2.42
Debt / Equity	34.62
Debt / EBITDA	1.91
Debt / FCF	-2.86
Interest Coverage	6.01

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	36.44%
Return on Invested Capital (ROIC)	46.45%
Return on Capital Employed (ROCE)	64.78%
Revenue Per Employee	2.34M
Profits Per Employee	720,136
Employee Count	22
Asset Turnover	1.14
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.68% in the last 52 weeks. The beta is 0.67, so ETR:NP5's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	+5.68%
50-Day Moving Average	8.91
200-Day Moving Average	8.73
Relative Strength Index (RSI)	47.01
Average Volume (20 Days)	6,156

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ETR:NP5 had revenue of EUR 51.39 million and earned 15.84 million in profits. Earnings per share was 0.77.

Revenue	51.39M
Gross Profit	51.39M
Operating Income	26.17M
Pretax Income	21.39M
Net Income	15.84M
EBITDA	26.20M
EBIT	26.17M
Earnings Per Share (EPS)	0.77

Full Income Statement

Balance Sheet

The company has 9.83 million in cash and 50.47 million in debt, giving a net cash position of -40.64 million.

Cash & Cash Equivalents	9.83M
Total Debt	50.47M
Net Cash	-40.64M
Net Cash Per Share	n/a
Equity (Book Value)	1.46M
Book Value Per Share	0.07
Working Capital	37.60M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -17.61 million and capital expenditures -13,000, giving a free cash flow of -17.63 million.

Operating Cash Flow	-17.61M
Capital Expenditures	-13,000
Free Cash Flow	-17.63M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 50.93% and 30.83%.

Gross Margin	100.00%
Operating Margin	50.93%
Pretax Margin	41.63%
Profit Margin	30.83%
EBITDA Margin	50.98%
EBIT Margin	50.93%
FCF Margin	n/a

Dividends & Yields

ETR:NP5 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.30%
Shareholder Yield	-15.30%
Earnings Yield	10.20%
FCF Yield	-11.35%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ETR:NP5 has an Altman Z-Score of 4.65.

Altman Z-Score	4.65
Piotroski F-Score	n/a